AP-HP, Hôpital Necker-Enfants Malades
Paris, 75015, France
NCT Number: NCT04117646
A single quality questionnaire evaluating the symptoms of chronic rhinosinusitis in children currently exists. It has been validated in English for children aged 2 to 12. It comprises five areas of quality of life, each rated by a score ranging from 1 to 7 : sinus infection, nasal obstruction, allergic symptoms, emotional distress and activity limitation, coupled with an overall assessment of quality of life with an analogue visual scale (score from 1 to 10). This SN-5 (sinus and nasal quality of life survey) score showed excellent statistics of reproducibility, internal validity and ease of response. It is currently used in several international publications evaluating chronic sinus pathology in children.
The objective of the study is to validate the translation of the SN-5 questionnaire in French.
Looking for future studies?
Notify Me2 year–12 year
All sexes
Observational
Paris, 75015, France
Chronic rhinosinusitis is a common pathology that entrains significant medical consumption. The prevalence of chronic rhinosinusitis in children is estimated to be 7.6%. Cardinal symptoms include nasal congestion, purulent rhinorrhea, facial pain, and persistent daytime cough. All these nasal symptoms often have an impact on the quality of life. The main objective of medical treatment is to improve this quality of life.
The treatment of chronic rhinosinusitis is mainly medical and includes nose washes with physiological serum, topical or general corticosteroid treatment or antibiotics. Surgical treatments such as adenoidectomy or endonasal functional surgery are reserved for medical treatment failures. According to a European consensus paper of 2012, the surgical strategy of the chronic rhinosinusitis of the child must start with a adenoidectomy with physiological serum washes, and then secondarily a endonasal functional surgery.
The ability of quality of life questionnaires to measure subjective symptoms over a certain length of time can help in the medical decision by determining the benefit of taking care. A single quality questionnaire evaluating the symptoms of chronic rhinosinusitis in children currently exists. It has been validated in English for children aged 2 to 12. It comprises five areas of quality of life, each rated by a score ranging from 1 to 7 : sinus infection, nasal obstruction, allergic symptoms, emotional distress and activity limitation, coupled with an overall assessment of quality of life with an analogue visual scale (score from 1 to 10). This SN-5 (sinus and nasal quality of life survey) score showed excellent statistics of reproducibility, internal validity and ease of response. It is currently used in several international publications evaluating chronic sinus pathology in children.
The objective of the study is to validate the translation of the SN-5 questionnaire in French.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Controls :
Exclusion criteria
French language not spoken by parents
Subjects respond to the translated questionnaire twice at 15 days apart.
Other names: Patient questionnaire
Time frame: 1 year
Reproducibility of the questionnaire completed by a subject at 15 days apart. Student t-test.
Time frame: 1 year
Measure of efficiency. Comparison of questionnaires completed by patients and controls.
Time frame: 1 year
Measure of efficiency. Comparison of questionnaires completed by patients and controls.
Time frame: 1 year
Measure of efficiency. Comparison of questionnaires completed by patients and controls.
Assistance Publique - Hôpitaux de Paris
Other
Acronym: SN5-FR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00318006
Bronchial Diseases, Bronchiolitis
Ann Arbor, Michigan, United States
View Trial DetailsNCT07470242
Chronic Rhinosinusitis
Pusan, South Korea
View Trial DetailsNCT07242040
Chronic Rhinosinusitis, Cognition Disorders
Cairo, Egypt
View Trial DetailsNCT05198518
Chronic Rhinosinusitis, Neurologic Manifestations
New York, United States
View Trial Details